臓器・組織移植の世界市場

Abstract

This report analyzes the worldwide markets for Organ And Tissue Transplantation by Number of Procedures. The specific product segments analyzed for the global and other markets (except the US) by Organ Type are Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine. The US market has been specifically analyzed both by Organ & Tissue Transplantation market, and Bone Graft Transplantation market. The report analyzes the US market for Organ & Tissue Transplantation both by Organ Type (Heart, Kidneys, Liver, Pancreas, and Lungs) and by Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts). Bone Graft Transplantation market in the US is analyzed both by Graft Type (Autologous Graft, Allograft, and Other Materials); and by Application Type (General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2012. The report profiles 77 companies including many key and niche players worldwide such as Abiomed Inc., Arbios Systems, Inc., CryoLife, Inc., Exactech, Inc., Fresenius Medical Care AG & Co. KGaA, Forticell Bioscience, Inc., Gambro AB, Genzyme Corporation, Jarvik Heart, Inc., LifeCell Corporation, Medtronic, Inc., MicroMed Cardiovascular, Inc., Organogenesis, Inc., SynCardia Systems, Terumo Corporation, Thoratec Corporation, Ventracor Limited, and WorldHeart Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• Tissue and Organ Transplantation
• Bone Graft Transplantation
• Product Definitions
• Organ Transplantation
• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation
• Pancreas Transplantation
• Small Intestine Transplantation
• Lungs
• Tissue Transplantation
• Corneal Transplantation
• Blood Stem Cell Transplantation
• Bone Marrow Transplantation
• Heart Valves Transplantation

II. EXECUTIVE SUMMARY

1. Introduction

2. Market Overview

• Current and Future Analysis
• Demand and Supply Imbalance
• Cardiac Arrest Death Patients - The Untapped Potential Donors
• Transplantation Expenses

3. Market Trends

• Living Donor Organs on the Rise
• Combined Organ Transplantation - Gaining Attention
• Awareness Programs and Education to Address Organ shortage
• Increasing Consent Rates - A Key Factor
• Transplant Tourism - Creating Brighter Avenues
• Alliances to Play a Key Role
• Graying Population and Chronic Diseases Surge Need for Transplants
• Fetal Tissue for Bionic Devices - Assuming Importance

4. Major Issues Impacting Transplantation Market

• Organ Rejection - A Major Barrier to Transplantation
• Scarcity of Donor Organs - A Stumbling Block in Organ Transplantation
• Other Issues for Organ Transplantation
• Ethical Concerns in Transplants
• Bioethical Issues Hindering Organ Donation Process
• Lack of Requisite Expertise - Hindering Implantation Process

5. Product Overview

• Tissue and Organ Transplantation
• Organ Transplantation
• Heart Transplantation
• Heart Diseases and Disorders
• Post Operative Complications and Consequences of Heart Transplants
• Bleeding
• Infection
• Arrythymia
• Heart Attack
• Coronary Artery Disease
• Respiratory Dysfunction
• Renal Dysfunction
• Graft Rejection and Dysfunction
• Death
• Kidney Transplantation
• Kidney Disorders and Diseases
• Donor Evaluation
• Waiting List
• Surgery/Post-Operation
• Post-Operative Supervision and Issues
• Liver Transplantation
• Liver Disorders and Diseases
• Pancreas Transplantation
• Post Operative Complications and Consequences of Pancreas Transplants
• Small Intestine Transplantation
• Intestine Disorders and Diseases
• Heart-and-Lung Transplantation
• Lung Transplantation
• Lung Diseases and Disorders
• Lung Patients Survival Statistics
• Tissue Transplantation
• Types of Grafts
• Autograft
• Allograft / Homograft
• Transplant Tolerance
• Isograft
• Xenograft
• Corneal Transplantation
• Penetrating Keratoplasty
• Lamellar (Non-Penetrating) Keratoplasty
• Aftercare
• Risks Associated with Corneal Transplants
• Transplantation Outcomes
• Morbidity and Mortality Rates
• Alternatives
• Blood Stem Cells
• Peripheral Blood Stem Cell Transplant
• Umbilical Cord Blood Stem Cell Transplant
• Bone Marrow and Hematopoietic Stem Cells
• Bone and Tissue Transplantation
• Bone Marrow Transplants
• Stem Cell Therapy
• Human Heart Valves
• Atrioventricular Valves
• Mitral Valve
• Tricuspid Valve
• Semilunar Valves
• Aortic Valve
• Pulmonic Valve
• Pathology of Valves
• Prosthetic Heart Valves
• Prosthetic Mechanical Valve
• Advantages
• Disadvantages
• Prosthetic Biologic Valve
• Advantages
• Disadvantages
• Fetal Cells
• Fetal Tissue for Transplantation
• Storage Duration Time
• Storage Time Period for Organs and Tissues
• Cold Ischemia Time
• Transplantation Immunology
• Acute Cellular Rejection
• Chronic Rejection
• Post Transplant Observations
• Types of Donors
• Alive Donors
• Related Donors
• Good Samaritans
• Rewarded/Forced Donors
• Deceased Donors
• Directed / Allocated
• Organs and Tissues Transplanted by Type of Donor
• Organ/Tissue Donation and Eligibility Criteria
• Factors Considered for Matching Recipients to Donor Organs
• Testing
• Blood Typing
• Tissue Typing
• Histocompatibility - A Major Barrier for Organ Transplantation
• Transplantation - Safety Requirements
• Waiting List
• Active Waiting List Patients
• Inactive Waiting List Patients
• History
• Major Milestones in Organ Transplantation

6. Artificial Organs

• Artificial Organs Revolutionize Medical Technology Industry
• Artificial Organs
• Categorization of Artificial Organs
• External Artificial Organs
• Internal or Implantable Artificial Devices
• Artificial Heart
• Total Artificial Heart (TAH)
• Ventricle Assist Device (VAD)
• Right Ventricular Assist Systems (RVAS)
• Left Ventricular Assist Systems (LVAS)
• Various Ventricle Assist Devices
• Artificial Kidney (Dialyzer)
• Limitations of Artificial Kidney
• Artificial Liver
• Various Liver Assist Devices
• Categorization of Liver Devices
• Mechanical Systems
• Bio-Artificial Systems
• Artificial Pancreas
• Artificial Lungs (Oxygenator)
• Types of Artificial Lung
• Artificial Cornea
• Keratoprostheses
• Tissue Engineered Corneas
• Artificial Skin/Skin Replacement Products
• AlloDerm Regenerative Tissue Matrix
• Apligraf
• Cymetra Micronized AlloDerm Tissue
• Dermagraft
• Epicel
• Integra Products
• OrCel
• TransCyte
• Core Competitive Factors
• Market Outlook for Artificial Organs

7. Preservation Solutions & Immunosuppressant Drugs

• Organ Preservation Solutions
• Celsior Solution
• Collins Solution
• Euro Collins Solution
• Custodiol® HTK Solution
• Hypothermosol
• ViaSpan
• Immunosuppressant Drugs
• Antibody Products for Treatment of Organ Transplant Rejection
• Antithymocyte Globulin
• ATGAM
• Campath/MabCampath
• Thymoglobulin
• Therapeutic Antibody Products
• Antiproliferative Agents
• Azathioprine
• CellCept
• Certican
• Myfortic
• Calcineurin Inhibitors
• Cyclosporine
• Gengraf
• Neoral
• Pulminiq
• Tacrolimus
• Prograf
• TOR Inhibitors
• Side Effects of Immunosuppression Therapy
• Select Immunosuppressant Drug Players
• Astellas Pharma US, Inc., (USA)
• F.Hoffmann-La Roche Ltd (Switzerland)
  • Novartis AG (Switzerland)
  • Wyeth (USA)

8. Regulatory Environment

• Transplant Center
• Organ Procurement Organization (OPO)
• Health Resources and Services Administration (HRSA)
• Division of Transplantation (DoT)
• United Network for Organ Sharing (UNOS)
• Organ Procurement and Transplantation Network (OPTN)
• University Renal Research and Education Association (URREA)
• Scientific Registry of Transplant Recipients (SRTR)
• Funding Sources
• Patient Education and Advocacy Organizations
• Legal Framework for Transplantation
• Legislation Covering Organ Transplant
• Organ Transplantation and Ethics
• Regulations Governing Artificial Organs

9. Product Development/Innovations

• Pluristem Develops New Cell Graft for Cancer Patients
• CryoLife Develops Cryopreserved Orthopaedic Tissues Implants
• Japanese Innovators Develop New Prognostic Scoring Model for Liver Transplants
• EUREKA project E! 2674 MIDAS Develops New Test to Improve Graft Survival

10. Recent Industry Activity

• St. Jude Medical’s Heart Valve Obtains US FDA Approval
• Zimmer and Tutogen Expand Distribution Partnership
• Leman Cardiovascular Acquires Hancock Jaffe Laboratories
• Nabi Acquires Commercialization Rights of ATG-Fresenius S for North America
• Cytopia and Novartis Ink Research Collaboration and Global License Agreement
• ZLB Behring Inks Agreement with MedImmune
• Japanese Team To Perform Liver Transplants in Hyderabad
• Nabi Bags Approval for HB Intravenous in Liver Transplant Patients
• Schering-Plough Announces PROTECT study Initiation
• Allegheny General Hospital To Establish Adult Liver Transplantation Center in Oakland
• Global Hospitals to Setup an Organ Transplant Center in Kolkata
• GCC to Establish Organ Transplant Center
• Delhi-Based Hospital Offers Help in Setting Up of Liver Transplant Center in Lahore
• Kaiser To Shut Down Kidney Transplant Center
• Abiomed Obtains FDA Approval for Selling Artificial Hearts
• Astellas Bags FDA Approval to Use Prograf in Heart Transplant Patients
• New York State Department of Health Approves Program for Kidney Transplant for Queen’s Community
• National Heart Institute Conducts First Double Lung Transplant in Malaysia
• The Netherlands Obtains Orphan Drug Designations for Treatment of DGF
• Papworth Transplants First Beating Human Heart in the UK
• Enzon to Return ATG-Fresenius S Rights to Fresenius Biotech
• Schering-Plough to Conduct ‘PROTECT’ Study
• Community Tissue Services Selects NOVA 2200 Supercritical Carbon Dioxide Sterilization Technology
• CryoLife Inks Agreement with The Magdi Yacoub Institute to Enhance Xenografts in Human Transplantation
• ReGen Inks Exclusive Marketing Deals with Polymedic and Xmedica
• University of California-Irvine Announces Closure of Liver-Transplantation Program
• Swedish Health Services Bags Approval for Liver Transplant Program
• New Organ Transplant Research Center in South Korea
• Child Lung Transplant Unit to be opened in Melbourne Hospital
• Narayana Hrudayalaya Health City Establishes Exclusive Organ Transplant Hospital
• Liver Transplant Facility in Delhi Region
• First Liver Transplant Research Institute in China
• PIMS to establish Liver Transplant Unit
• Liver Transplant Programme in Pakistan
• Isotechnika Gains FDA Approval
• FDA Offers Approval for Brain Stem Cell Transplant Trial
• Methodist Specialty and Transplant Hospital Gains Approval to Execute Liver Transplants
• Cubist Pharmaceuticals Enters into Licensing Agreement with XTL Biopharmaceuticals
• Jackson Memorial Receives Approval from the U.S. Centers for Medicare and Medicaid Services
• Royal Perth Hospital to Open Lung Transplant Unit in Perth
• Mater Hospital Opens Lung Transplant Unit in Dublin
• Genzyme Makes a Synergistic Purchase of Ilex Oncology
• NIAID Sets Up Clinical Consortium to Enhance Organ Transplants Success
• Chiron files NDA for Pulminiq Inhalation Solution
• Roche Acquires IL-15 Antagonist
• Genzyme Completes Acquisition of SangStat

11. Focus on Select Global Players

• Abiomed Inc (USA)
• Arbios Systems, Inc. (USA)
• CryoLife, Inc.(USA)
• Exactech, Inc. (USA)
• Fresenius Medical Care AG & Co. KGaA (Germany)
• Forticell Bioscience, Inc. (USA)
• Gambro AB (Sweden)
• Genzyme Corporation (USA)
• Jarvik Heart, Inc. (USA)
• LifeCell Corporation (USA)
• Medtronic, Inc. (USA)
• MicroMed Cardiovascular, Inc. (USA)
• Organogenesis, Inc. (USA)
• SynCardia Systems (USA)
• Terumo Corporation (Japan)
• Thoratec Corporation (USA)
• Ventracor Limited (Australia)
• WorldHeart Corporation (USA)

12. Global Market Perspective

• Table 1: World Recent Past, Current & Future Market Analysis for Organ Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 2: World 10-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 3: World Recent Past, Current & Future Market Analysis for Heart Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 4: World 10-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 5: World Recent Past, Current & Future Market Analysis for Kidney Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 6: World 10-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 7: World Recent Past, Current & Future Market Analysis for Liver Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 8: World 10-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 9: World Recent Past, Current & Future Market Analysis for Pancreas Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 10: World 10-Year Perspective for PancreasTransplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 11: World Recent Past, Current & Future Market Analysis for Lung Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 12: World 10-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 13: World Recent Past, Current & Future Market Analysis for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 14: World 10-Year Perspective for Corneal Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Current and Future Analysis
  • Analysis by Value Sales
  • Liver Transplantation Sustains Dominance
  • Skin Grafts Take the Largest Chunk
  • Analysis by Number of Procedures
  • Intestine - Fastest Growing Segment
  • Skin Grafts - Largest and Fastest GrowingTissue Segment
  • Bone Graft Procedure Volume by Graft Typeand Application
  • US Organ Transplant Facts and Figures
  • Number of Organ Transplants WitnessesPhenomenal Surge-2004
  • Increasing Organ Donations in New Jersey
  • Innovative Means of Organ Procurement to IncreaseOrgan Donations
  • A New Technique to Enhance and Extend KidneyTransplants
  • California Stands Up Against Insurance onHIV Patients’ Transplantation
  • Awareness Programs to Address Shortage ofMinority Donors
  • Organs and Tissues on A Recovery Spree
  • Unexamined Human Tissue Transplants - A MajorThreat
  • Defective Medical Implants - A Health Hazard
  • Eye Infections from Usage of MoistureLoc Leadsto Corneal Transplants
  • Sources of Donor Organs
  • Table 15: US Kidney Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 16: US Liver Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 17: US Heart Donations by Cadaveric Donor Type for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 18: US Lung Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 19: US Pancreas Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 20: US Intestine Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Lung Transplantation
  • Lung Transplant Death Rates
  • Heart-Lung Transplantation
  • Incidence of Organ Transplants
  • Table 21: Incidence of Organ Transplant Type for Kidney, Liver, Heart, Lung, Pancreas, Intestine, and Heart-Lung Transplants per 1 Million Population in the US for the Year 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 22: Incidence of Organ Transplants (Kidney, Liver, Heart, Lung, Pancreas, Intestine, and Heart-Lung) per 1 Million Population in the US by Recipient Race (White, African American, Asian, Hispanic, and Other) for 2005 (includes corresponding Graph/Chart)
  • Table 23: Incidence of Organ Transplants (Kidney, Liver, Heart, Lung, Pancreas, Intestine, and Heart-Lung) per 1 Million Population in the US by Recipient Gender (Male, and Female) for 2005 (includes corresponding Graph/Chart)
  • Table 24: Incidence of Organ Transplants (Kidney, Liver, Heart, Lung, Pancreas, Intestine, and Heart-Lung) per 1 Million Population in the US by Recipient Age (65+ Years, 50-64 Years, 35-49 Years, 18-34 Years, 11-17 Years, 6-10 Years, 1-5 Years, <1 Year) for 2005 (includes corresponding Graph/Chart)
  • Waiting List
  • Table 25: Waiting List of Patients As of July 2007 (includes corresponding Graph/Chart)
  • Table 26: Waiting List of Active and Inactive Patients for Years 2004 & 2005 (includes corresponding Graph/Chart)
  • Waiting List for Heart Transplants
  • Table 27: Waiting List of Active Patients for Heart for Years 2000 to 2005 (includes corresponding Graph/Chart)
  • Categorized by Diseases
  • Categorized by Age
  • Categorized by Race
  • Death Rates on Waiting List
  • Kidney Transplantation Waiting List
  • Categorized by Age
  • Categorized by Race
  • Waiting List for Liver Transplants
  • Categorized by Age
  • Categorized by Race
  • Categorized by Gender
  • Categorized by Diseases
  • Categorized by Re-Transplant Necessity
  • Death Rates on Waiting List
  • Pancreas Transplant Waiting List
  • Simultaneous Pancreas Kidney TransplantationWaiting List
  • Pancreas After Kidney and Pancreas TransplantAlone Transplant Waiting List
  • Waiting List for Lung Transplants
  • Categorized by Age
  • Categorized by Primary Diagnoses
  • Categorized by Gender and Ethnic Makeup
  • Waiting Time for Lung Transplant
  • Annual Death Rates
  • Waiting List for Intestine Transplants
  • Death Rates on Waiting List
  • Patient Survival Rate
  • Table 28: Patient Survival Percent by Organ Type for 1-Year and 5-Years (includes corresponding Graph/Chart)
  • Annual Death Rate of Kidney Recipients
  • Pancreas Patient Survival Rate
  • Pancreas Graft Survival Rate
  • Immunosuppression Therapy
  • Immunosuppression Therapy for Heart TransplantRecipients
  • Table 29: Usage Rates of Major Immunosuppressants in 2004 (includes corresponding Graph/Chart)
  • Immunosuppression Therapy for Kidney TransplantRecipients
  • Immunosuppression Therapy for PancreasTransplants
  • Immunosuppression Therapy for Lung TransplantRecipients
  • Table 30: Usage Rates of Induction Therapies in 2005 (includes corresponding Graph/Chart)
  • Immunosuppression Therapy Following BoneMarrow Transplantation
  • Table 31: US Recent Past, Current & Future Market Analysis for Immunosuppressive Drug Therapy Following Bone Marrow Transplantation by Category - For GVHD and Maintenance Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Immunosuppression Therapy Following BloodStem Cell Transplantation
  • Table 32: US Recent Past, Current & Future Market Analysis for Immunosuppressive Drug Therapy Following Blood Stem Cell Transplantation by Category - For GVHD and Maintenance Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • United Network for Organ Sharing
  • The American Association of Tissue Banks(AATB)
  • Accredited Banks from Select US States
  • Eye Banks from Select US States
  • Number of Transplant Center Programs
  • Table 33: Number of Transplant Center Programs for the Years 1990, 1997 and 2000 (includes corresponding Graph/Chart)
  • Table 34: Average Number of Transplants Per Program for the Years 1990, 1997 and 2000 (includes corresponding Graph/Chart)
  • Strategic Developments
  • Select Players
  • Abiomed Inc
  • Arbios Systems Inc.
  • Arrow International, Inc.
  • CryoLife, Inc.
  • Exactech, Inc.
  • Genzyme Corporation
  • Jarvik Heart Inc.
  • LifeCell Corporation
  • Medtronic Inc
  • MicroMed Cardiovascular, Inc.
  • Organogenesis Inc
  • Forticell Bioscience, Inc.
  • SynCardia Systems
  • Thoratec Corporation
  • WorldHeart Corporation
• B. Market Analytics
  • Table 35: US Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 36: US 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
  • Table 37: US Recent Past, Current & Future Market Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart Valves and Skin Grafts Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 38: US 10-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Dollar Sales for Cornea, Heart Valves and Skin Grafts Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
  • Table 39: US Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 40: US 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
  • Table 41: US Recent Past, Current & Future Market Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 42: US 10-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Number of Procedures for Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
  • Table 43: US Recent Past, Current & Future Market Analysis for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 44: US 10-Year Perspective for Bone Graft Transplantation by Graft Type - Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart) (includes corresponding Graph/Chart)
  • Table 45: US Recent Past, Current & Future Market Analysis for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 46: US 10-Year Perspective for Bone Graft Transplantation by Application - Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

2. Canada

• A. Market Analysis
  • Current and Future Analysis
  • Canadians More Receptive to Organ Transplants
  • Waiting List
  • Table 47: Canadian Patients (Active and Inactive) on Waiting List by Organ Type for 2005 & 2006 (includes corresponding Graph/Chart)
  • Organ Donation
  • Success Rate of Organ Transplants
  • Table 48: Success Rate of Organ Transplants After 1-Year (includes corresponding Graph/Chart)
  • Strategic Development
• B. Market Analytics
  • Table 49: Canadian Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 50: Canadian 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

3. Europe

• A. Market Analysis
  • Current and Future Analysis
  • Italy
  • Surge in Organ Transplants
  • The United Kingdom
  • Organ and Tissue Transplantation in the UK
  • Table 51: UK Organ Transplantations for the Years 2003 and 2004 (includes corresponding Graph/Chart)
  • Table 52: Waiting List (Active and Inactive) by Organ Type in the UK for the Years 2003 and 2004 (includes corresponding Graph/Chart)
  • Kidney Transplantation
  • Waiting List
  • Categorized by Race
  • Categorized by Age and Sex
  • Donors and Transplantation Recipients
  • Categorized by Race
  • Categorized by Age and Gender
  • Pancreas Transplantation
  • Waiting List
  • Categorized by Race
  • Categorized by Age and Gender
  • Donors and Transplantations
  • Categorized by Race
  • Categorized by Age and Gender
  • Lung Transplant Record Numbers Boasts ofLung Power
  • Bladder Transplantation A Roaring Success
  • Russia
  • Organ Transplantations Show a Downward Trendin Russia
  • Turkey
  • Akdeniz University - A World-RenownedTransplantation Center
  • Strategic Developments
  • Select Players
  • Fresenius Medical Care AG & Co. KGaA(Germany)
  • Gambro AB (Sweden)
• B. Market Analytics
  • Table 53: European Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 54: European 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

4. Asia

• A. Market Analysis
  • Current & Future Analysis
  • Australia
  • Australia Registers Highest Success Rate inTransplantation
  • Kidney Transplantation Snapshots
  • Organ Donor Register
  • China
  • Organ Transplantations in China
  • Transplantation Tourism in China
  • Low Transplant Success Rate Due to UnskilledProfessionals
  • Cost Effective Transplant Procedures Lure ForeignPatients
  • Illegal Activities for Harvesting Organs in China
  • Regulations on Organ Transplantation
  • Regulations on Brain Death
  • India
  • Overview of Renal Transplantation
  • Transplantation Expenses in India
  • Indian Government to amend OrganTransplantation Rules
  • Singapore
  • Awareness Programs to Increase Living KidneyDonations in Singapore
  • Taiwan
  • Taiwan Competes with the US in Kidney and LiverTransplant Survival Rates
  • Strategic Developments
  • Select Players
  • Terumo Corporation (Japan)
  • Ventracor Limited (Australia)
• B. Market Analytics
  • Table 55: Asia Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 56: Asia 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

5. Latin America

• A. Market Analysis
  • Current & Future Analysis
  • Brazil - A Major Transplant Market
• B. Market Analytics
  • Table 57: Latin America Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 58: Latin America 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

6. Rest of World

• A. Market Analysis
  • Current & Future Analysis
  • Kuwait - A Rapidly Emerging ‘Third World’Country in Organ Transplants
  • Strategic Development
• B. Market Analytics
  • Table 59: Rest of World Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 60: Rest of World 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

ご注意：当報告書はDRM（デジタル著作権管理システム）付PDFとなります。 PDFのダウンロード・閲覧にはAdobe Acrobat Reader Ver. 7.0 が必要となります。ご購入頂いた場合、同Acrobat Reader （ご購入時無償配布）をPCにインストールして頂き、ダウンロードを行ったPC上のみでの閲覧と、1回のプリントアウトが可能となっております。ご不明な点につきましてはお問合せください。